[ad_1]
(AOF) – It is now done. In parallel with its annual activity update, LNA Santé announced on Thursday the completion of a capital increase in the amount of 50 million euros (issue premium included), at a price of 52.50 euros per share. . An operation which aims to strengthen the capital of the operator of Ehpad.
This operation involved 700 employees in the investment company LNA Ensemble, a reinvestment by Siparex, Unexo and Sodero Gestion, who have been supporting the group since 2011, and the new association with its strategic plan of the SMA group and BNP Paribas Development alongside of the founders.
“By associating its business plan over the long term with both its teams in the diversity of their businesses and their functions, strategic partners and local investors, we are convinced that our business orientations, the quality of our knowledge -doing internally and the full mobilization of our employees will ensure the success and growth of our company in the service of its customers in each of the health territories”, commented Jean-Paul Siret, President of LNA Santé.
AOF – LEARN MORE
Boost for French pharmacy
At the end of a recent CSIS, the French authorities announced an amount of credits (7 billion euros) never reached: 1.5 billion for hospital-university research, 2 billion for investment in health via bpi france , 1.5 billion in aid for the relocation of industrial projects, and 2 billion to strengthen investment in three sectors of the future (bioproduction, digital medicine, and pandemic preparedness). In addition, the annual growth in drug expenditure reimbursed by Medicare will be 2.4%, which should generate growth of at least 0.5% in the turnover of laboratories,
Above all, the normal drug marketing procedure will be accelerated (up to 500 days saved) if the medical benefit rendered is sufficient.
[ad_2]
Source link -86